Life Sciences

Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Deloitte LLP’s Life Sciences practice works with our clients to shape the evolution of the industry.

Learn more about our Health Sciences practice and Deloitte Recap.

MoreFeatured Insights

Dbriefs webcast on medical device excise tax: New proposed regulations may have broad implications for affected companies
Webcast will focus on IRS released proposed regulations, released On February 3, the under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010. Medical device sales will be subject to a new 2.3 percent excise tax beginning January 1, 2013.
Tax by industry: Life sciences
This piece focuses on the Medical Device Excise Tax, a provision of the Healthcare Reform legislation, enacted March 30, 2010, and aims to highlight potential areas of consideration for readiness in anticipation further guidance in early 2012.
@Regulatory special bulletin
Proposed regulatory provisions impacting Average Manufacturer Price, Best Price and Medicaid Unit Rebate Amount present significant challenges for manufacturers to implement.
2012 Outlook on health care, life sciences and government
Deloitte LLP's Paul Keckley, Ph.D., executive director of the Deloitte Center for Health Solutions, and John Bigalke, vice chairman and U.S. national industry leader, Health Sciences & Government, share their outlook on the year ahead.
CBI Pharma/Biotech Accounting & Reporting Congress 2012
Deloitte is proud to again serve as the Lead Summa sponsor for this prestigious conference for financial and accounting executives in the life sciences industry.

Join Our Team

Explore Health Sciences career opportunities: Experienced Hires | Students

Stay Updated

Subscribe to receive updates from Deloitte's Life Sciences practice:
Life Sciences Email E-mail | Life Sciences RSS RSS ( What is RSS?) | Life Sciences Twitter Twitter